Rhu-pGSN for Severe Covid-19 Pneumonia
Clinical trial NCT04358406 · COMPLETED
Trial details
- NCT number
- NCT04358406
- Sponsor
- BioAegis Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2021-05-25
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.